1-3 of 3
Yanqing Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from the Great Britain AML Real World Evidence (ARC) Initiative - a Centre-Based Chart Review Study to Assess Treatment Outcomes of Venetoclax for the Treatment of Acute Myeloid Leukemia

Jenny O'Nions, Gerardo Errico, Lajos Floro, Vidhya Murthy, Connor Sweeney, Harpreet Kaur, Unmesh Mohite, Robert Ayto, Caroline Alvares, Aaron D. Goldberg, Kathryn Moulton, Hanna Kew, Ewa Kalinowska, Yanqing Xu, Paresh Vyas
Journal: Blood
Blood (2024) 144 (Supplement 1): 7932.
https://doi.org/10.1182/blood-2024-209926
Published: 2024
Journal Articles

Inequalities in Treatment Utilization Among Older Medicare Beneficiaries with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Induction Therapy

Amer M. Zeidan, Yanqing Xu, Tatyana A. Kapustyan, Kaylee Miu, Cheng Chen, Rajesh Kamalakar, Chia-Wei Lin, Esprit Ma, Melissa Montez, Zheng Wu, Tracy Yee, Haiyan Sun, Andrew Rava, Sonia Kim, Scott F Huntington
Journal: Blood
Blood (2024) 144 (Supplement 1): 3795.
https://doi.org/10.1182/blood-2024-200213
Published: 2024
Journal Articles

Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada

Kimberly Guinan, Laurie Demers-Rozon, Monika Ham, Yoann Brassard, Nancy Paul Roc, Paola Lembo, Grace Christou, Christopher Lemieux, Stephane Barakat, Yanqing Xu, Mathieu Pelletier, Jean Lachaine
Journal: Blood
Blood (2024) 144 (Supplement 1): 5057.
https://doi.org/10.1182/blood-2024-207342
Published: 2024